Host range and interference studies of three classes of pig endogenous retrovirus

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9986-9991

  Takeuchi, Yasuhiro ^a   Patience, Clive ^a   Magre, Saema ^a   Weiss, Robin A ^a   Banerjee, Papia T ^b   Le Tissier, Paul ^c   Stoye, Jonathan P ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b BioTransplant Inc   (United States)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SWINE; TRANSACTIVATION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS REPLICATION; XENOTRANSPLANTATION;

EID: 0031774860     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9986-9991.1998     Document Type: Article

References (40)

1. Advisory Group on the Ethics of Xenotransplantation for the Department of Health. 1997. Animal tissue into humans. Her Majesty's Stationery Office, Norwich, England.
2. Akiyoshi, D. E., Denaro, M., H. Zhu, J. L. Greenstein, P. T. Banerjee, and J. A. Fishman. 1998. Identification of a full-length cDNA for n endogenous retrovirus of miniature swine. J. Virol. 72:4503-4507.
3. Allan, J. S. 1996. Xenotransplantation at a crossroads: prevention versus progress. Nat. Med. 2:18-21.
4. Battini, J. L., O. Danos, and J. M. Heard. 1995. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69:713-719.
5. Battini, J. L., J. M. Heard, and O. Danos. 1992. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66:1468-1475.
6. Butler, D. 1998. Last chance to stop and think on risks of xenotransplants. Nature 391:320-324.
7. Cosset, F. L., F. J. Morling, Y. Takeuchi, R. A. Weiss, M. K. Collins, and S. J. Russell. 1995. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:6314-6322.
8. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
9. Deacon, T., J. Schumacher, J. Dinsmore, C. Thomas, P. Palmer, S. Kott, A. Edge, D. Penney, S. Kassissieh, P. Dempsey, and O. Isacson. 1997. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3:350-353.
10. Fishman, J. A. 1994. Miniature swine as organ donors for man: strategies for prevention of xenotransplant-associated infections. Xenotransplantation 1: 47-57.
11. Gage, F. H. 1998. Cell therapy. Nature 392(Suppl.):18-24.
12. Galili, U., and K. Swanson. 1991. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc. Natl. Acad. Sci. USA 88:7401-7404.
13. Groth, C. G., O. Korsgren, A. Tibell, J. Tollemar, E. Moller, J. Bolinder, J. Ostman, F. P. Reinholt, C. Hellerstrom, and A. Andersson. 1994. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:1402-1404.
14. Hamadeh, R. M., G. A. Jarvis, U. Galili, R. E. Mandrell, P. Zhou, and J. M. Griffiss. 1992. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J. Clin. Investig. 89:1223-1235.
15. Larsen, R. D., C. A. Rivera Marrero, L. K. Ernst, R. D. Cummings, and J. B. Lowe. 1990. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J. Biol. Chem. 265:7055-7061.
16. Le Tissier, P., J. P. Stoye, Y. Takeuchi, C. Patience, and R. A. Weiss. 1997. Two sets of human-tropic pig retrovirus. Nature 389:681-682.
17. Le Tissier, P., and J. P. Stoye. Unpublished data.
18. Loiler, S. A., N. L. DiFronzo, and C. A. Holland. 1997. Gene transfer to human cell using retrovirus vectors produced by a new polytropic packaging cell line. J. Virol. 71:4825-4828.
19. Makowa, L., D. V. Cramer, A. Hoffman, M. Breda, L. Sher, G. Eiras-Hreha, P. J. Tuso, C. Yasunaga, C. A. Cosenza, G. D. Wu, F. A. Chapman, and L. Podesta. 1995. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 59:1654-1659.
20. Michaels, M. G. 1997. Infectious concerns of cross-species transplantation. xenozoonoses. World J. Surg. 21:968-974.
21. Miller, D. G., and A. D. Miller. 1992. Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor. J. Virol. 66:78-84.
22. Miyazono, K., T. Okabe, A. Urabe, F. Takaku, and C. H. Heldin. 1987. Purification and properties of an endothelial cell growth factor from human platelets. J. Biol. Chem. 262:4098-4103.
23. Patience, C., G. S. Patton, Y. Takeuchi, R. A. Weiss, M. O. McClure, L. Rydberg, and M. E. Breimer. 1998. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 352:699-701.
24. Patience, C., Y. Takeuchi, and R. A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3:282-286.
25. Patience, C. Unpublished data.
26. Phan Thanh, L., B. Kaeffer, and E. Bottreau. 1992. Porcine retrovirus: optimal conditions for its biochemical detection. Arch. Virol 123:255-265.
27. Platt, J. L. 1998. New directions for organ transplantation. Nature 392(Suppl.):11-17.
28. Porter, C. D., M. K. Collins, C. S. Tailor, M. H. Parkar, F. L. Cosset, R. A. Weiss, and Y. Takeuchi. 1996. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum. Gene Ther. 7:913-919.
29. Sachs, D. H. 1996. Transplantation. Curr. Opin. Immunol. 8:671-673.
30. Silver, J., T. Maudru, K. Fujita, and R. Repaske. 1993. An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. Nucleic Acids Res. 21:3593-3594.
31. Sommerfelt, M. A., and R. A. Weiss. 1990. Receptor interference groups of 20 retroviruses plating on human cells. Virology 176:58-69.
32. Stoye, J. P., and J. M. Coffin. 1995. The dangers of xenotransplantation. Nat. Med. 1:1100.
33. Stoye, J. P., P. Le Tissier, Y. Takeuchi, C. Patience, and R. A. Weiss. Endogenous retroviruses: a potential problem for xenotransplantation? Ann. N. Y. Acad. Sci., in press.
34. Suzuka, I., N. Shimizu, K. Sekiguchi, H. Hoshino, M. Kodama, and K. Shimotohno. 1986. Molecular cloning of unintegrated closed circular DNA of porcine retrovirus. FEBS Lett. 198:339-343.
35. Tailor, C. S., Y. Takeuchi, B. O'Hara, S. V. Johann, R. A. Weiss, and M. K. Collins. 1993. Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. J. Virol. 67:6737-6741.
36. Takeuchi, Y., F. L. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M. K. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68. 8001-8007.
37. Takeuchi, Y., G. Simpson, R. G. Vile, R. A. Weiss, and M. K. Collins. 1992. Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. Virology 186:792-794.
38. Takeuchi, Y., R. G. Vile, G. Simpson, B. O'Hara, M. K. Collins, and R. A. Weis. 1992. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J. Virol. 66:1219-1222.
39. Talbot, S. J., R. A. Weiss, and T. F. Schulz. 1995. Reduced glycosylation of human cell lines increase susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B). J. Virol. 69:3399-3406.
40. Wilson, C. A., S. Wong, J. Muller, C. E. Davidson, T. M. Rose, and P. Burd. 1998. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol. 72:3082-3087.